Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.000
+0.010 (1.01%)
Jun 20, 2025, 4:00 PM - Market closed
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $30.09 million as of June 23, 2025. Its market cap has decreased by -52.08% in one year.
Market Cap
30.09M
Enterprise Value
25.16M
1-Year Change
-52.08%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $30.09M, a decrease of -68.26%. That is a compound annual growth rate of -16.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 27.40M | -47.10% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |